FDA Issues Warning Letters on STD “Treatments” Sold Online
From the FDA’s release: “The U.S. Food and Drug Administration today issued Warning Letters to six U.S. companies and one foreign individual for marketing unapproved and misbranded drugs over the Internet to U.S. consumers for the prevention and treatment of sexually transmitted diseases (STDs).”
The products are sold as Tetrasil, Genisil, Aviralex, OXi-MED, Imulux, Beta-mannan, Micronutrient, Qina, and SlicPlus, and FDA is advising consumers to stop using them immediately. They are not FDA approved, and the agency has raised concerns about inadequate directions and false or misleading claims.
It’s interesting to me that the FDA’s warning letters to the companies, in listing the promotional claims about the product, mentions the metatags of the websites – for example, “These claims are supplemented by the metatags that you use to bring consumers to your website. The metatags include ‘herpes treatment,’ ‘herpes genital treatment,’ and ‘herpes simplex treatment.'” In other words, luring people to the website with keywords unsupported by the medical evidence may also be a form of false/misleading claim.
Update: JUnkfood Science has commentary on this as well.